Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a New Score Incorporating Endothelial Dysfunction for the Assessment of Coronary Heart Disease Risk in Patients With Rheumatoid Arthritis: a 3-year Prospective Study.

NCT02341066 is registered in ClinicalTrials.gov with Azienda Ospedaliero Universitaria di Sassari as lead sponsor.

NCT NCT02341066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02341066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a New Score Incorporating Endothelial Dysfunction for the Assessment of Coronary Heart Disease Risk in Patients With Rheumatoid Arthritis: a 3-year Prospective Study.
Lead sponsor
Azienda Ospedaliero Universitaria di Sassari
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2015
Completion date
March 31, 2019
Enrollment
3,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease, rheumatoid arthritis